2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and levodopa

2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline has been researched along with levodopa in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Moser, A; Qadri, F; Thümen, A	1

Other Studies

1 other study(ies) available for 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and levodopa

Article	Year
Modulation of striatal serotonin and opioid receptor mRNA expression following systemic N-methyl-norsalsolinol administration. Journal of the neurological sciences, 2003, Dec-15, Volume: 216, Issue:1 Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Gene Expression; Levodopa; Male; Neostriatum; Parkinson Disease; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Opioid, delta; Receptors, Opioid, mu; RNA, Messenger; Serotonin; Tetrahydroisoquinolines; Up-Regulation	2003

Article

Year

Modulation of striatal serotonin and opioid receptor mRNA expression following systemic N-methyl-norsalsolinol administration.

Journal of the neurological sciences, 2003, Dec-15, Volume: 216, Issue:1

Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Gene Expression; Levodopa; Male; Neostriatum; Parkinson Disease; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Opioid, delta; Receptors, Opioid, mu; RNA, Messenger; Serotonin; Tetrahydroisoquinolines; Up-Regulation

2003